% Bibliography for hypothesis h-89f1963f
% Title: Hypothesis 2: GPNMB-CD44 Axis as Anti-inflammatory Pathway
% Generated: 2026-04-27T16:28:30Z

@article{pmid41695273,
  title = {The temporal and stimuli-specific effects of LPS and IFNγ on microglial activation.},
  author = {Heiss CN, Naylor AS, Pesämaa I, Meshi A, Céspedes-Cortés B et al.},
  journal = {Front Aging Neurosci},
  year = {2026},
  pmid = {41695273},
  doi = {doi: 10.3389/fnagi.2026.1756410},
  url = {https://pubmed.ncbi.nlm.nih.gov/41695273/},
}

@article{pmid37684253,
  title = {CD44 connects autophagy decline and ageing in the vascular endothelium.},
  journal = {Nat Commun},
  year = {2023},
  pmid = {37684253},
}

@article{pmid35249813,
  title = {The membrane receptor CD44: novel insights into metabolism.},
  journal = {Trends Endocrinol Metab},
  year = {2022},
  pmid = {35249813},
}

@article{pmid34944493,
  title = {CD44: A Multifunctional Mediator of Cancer Progression.},
  journal = {Biomolecules},
  year = {2021},
  pmid = {34944493},
}

@article{pmid29519253,
  title = {The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptor.},
  author = {["Matthew L Neal", "Alexa M Boyle", "Kevin M Budge", "Fayez F Safadi", "Jason R Richardson"]},
  journal = {Journal of neuroinflammation},
  year = {2019},
  pmid = {29519253},
  doi = {10.1186/s12974-018-1100-1},
}

@article{pmid25081531,
  title = {HAS2 and CD44 in breast tumorigenesis.},
  journal = {Adv Cancer Res},
  year = {2014},
  pmid = {25081531},
}